-
Mashup Score: 1People with Lupus Who Have Certain Antibodies Are More Likely to Experience Blood Clots, Researchers Find - 17 day(s) ago
Some patients with lupus who possess specific antibodies are at a higher risk of thrombotic events such as a blood clot, stroke or heart attack, a new study led by Johns Hopkins Medicine researchers shows. The finding might help clinicians determine which patients may need early treatment and clinical monitoring for thrombotic events. Normally, antibodies help protect the body by fighting infections and tumors, but in autoimmune conditions such as lupus, antibodies may go after healthy tissues and
Source: www.hopkinsmedicine.orgCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 125 Years of Advances in Neurosurgery - 23 day(s) ago
Henry Brem reflects on his time leading the Johns Hopkins Department of Neurosurgery.
Source: www.hopkinsmedicine.orgCategories: General Medicine NewsTweet
-
Mashup Score: 14
The study, partly funded by the National Institutes of Health, was published May 22 in Cancer Discovery. Investigators were surprised they could detect cancer-derived mutations in the blood so much earlier, says lead study author Yuxuan Wang, M.D., Ph.D., an assistant professor of oncology at the Johns Hopkins University School of Medicine. “Three years earlier provides time for intervention. The tumors are likely to be much less advanced and more likely to be curable.” To determine how early cancers
Source: www.hopkinsmedicine.orgCategories: General Medicine NewsTweet
-
Mashup Score: 3HPV Drives Tumor Development in Rare Nasal Cancers - 29 day(s) ago
Human papillomavirus (HPV) can drive tumor development in some rare sinonasal squamous cell carcinomas (SNSCCs), according to a new comprehensive study of these tumors from investigators at the Johns Hopkins University School of Medicine and the Johns Hopkins Kimmel Cancer Center. The researchers also identified common mutations among these cancers and a potential combination treatment during the study, which was partially supported by the National Institutes of Health. The origin of SNSCCs has been
Source: www.hopkinsmedicine.orgCategories: General Medicine NewsTweet
-
Mashup Score: 1Pamela Tucker Course in Transplant & Oncology Infectious Diseases - 1 month(s) ago
This activity has been approved for AMA PRA Category 1 Credits ™. REGISTRATION DEADLINE: SEPTEMBER 2, 2025 | 5:00 PM Registering for this course includes 2 full days of in-person learning and access to our online course, Advanced Topics in Clinical Infectious Diseases and Antimicrobial Resistance. Get access to this online course when you register for our in-person course, Transplant and Oncology Infectious Diseases. Learn more about the life and legacy of Dr. Pamela Tucker. This two-day, in-person
Source: www.hopkinsmedicine.orgCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 1How Sunglasses Help Protect Your Eyes' Health - 2 month(s) ago
Our eyes are as sensitive our skin is to the sun, but we often treat sunglasses as optional. Dr. Bryce St. Clair explains how sunglasses matter for your eye health, what to look for when looking for sunglasses, and when to wear sunglasses to protect your eyes.
Source: www.hopkinsmedicine.orgCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 2AI-Based Liquid Biopsy Shows Promise for Detecting Brain Cancer - 2 month(s) ago
Several states are reporting cases of measles, a highly contagious viral disease. Both children and adults can get measles. Before going to a clinic or emergency room, it’s important to check with your doctor if you think you or a loved one has measles. A new liquid biopsy approach developed by Johns Hopkins Kimmel Cancer Center investigators could revolutionize brain cancer detection by identifying circulating DNA fragments from tumors and immune cells in blood samples, potentially enabling earlier
Source: www.hopkinsmedicine.orgCategories: General Medicine NewsTweet
-
Mashup Score: 3Johns Hopkins Venous Thromboembolism Symposium - 4 month(s) ago
The Johns Hopkins Venous Thromboembolism Collaborative holds an annual symposium in March that highlights some of the latest research on blood clots prevention.
Source: www.hopkinsmedicine.orgCategories: General Medicine News, Cardiology News and JournTweet-
The 16th Annual VTE Symposium presented by @HopkinsMedicine is Fri, 3/29 from 8 am-12:30 pm via livestream and in person. Learn more and register: https://t.co/DKlp8B57bf #stoptheclot #bcam #bcam2024 #vte #bloodclots #bloodclotresearch #johnshopkins @elliotthaut #drjamesdouketis https://t.co/cyVPYNw8Av
-
-
Mashup Score: 1
Baltimore Region: Due to the recent collapse of the Francis Scott Key Bridge, please anticipate delays when travelling to appointments. More information. Adding a personalized anti-tumor vaccine to standard immunotherapy is safe and about twice as likely to shrink cancer as standard immunotherapy alone for patients with hepatocellular carcinoma, the most common type of liver cancer, according to a clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center and its Convergence Institute.
Source: www.hopkinsmedicine.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Two Johns Hopkins Medicine Scientists Win Harvey Prize - 7 month(s) ago
Like many medical facilities across the nation, our supply chain is feeling the effects of Hurricane Helene’s aftermath. Johns Hopkins Medicine currently has a sufficient sterile fluid supply to meet treatment, surgical and emergency needs. However, we have put proactive conservation measures into place to ensure normal operations, always with patient safety as our first priority. Examples of sterile fluids include intravenous (IV), irrigation and dialysis fluids. Learn more. Baylin, co-director of the
Source: www.hopkinsmedicine.orgCategories: General Medicine News, Onc News and JournalsTweet
Research led by Drs. Eduardo Gomez-Banuelos and Felipe Andrade at Johns Hopkins found that anti-TFAM antibodies are associated with thrombosis in patients with lupus. Learn more about these emerging findings and their potential here: https://t.co/kLYpPRGDom